http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004082630-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa74871ab2e2178c7987dd7b6252c890
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a63dd835324b0ad323d05159c18f052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_146a82957ad7291ef07efaee7f9e302a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a4b6fbb917660fdcba22a1da26b228b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26227fa9e75b62858946644d43ba7bfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81cdf8344bbaf6b2ddcf2026f3820f74
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-002
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate 2004-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bc3dfc0bac2fda8823c94632bc2f322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_882f15a83095dac5697b30a8a540ff5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c588af1ad2e9a82c5fc84228cdcb2fd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6844a36e7769fd5e91ee525efaf10eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71dd7c5a4b5e68663cdd4ffb6e332708
publicationDate 2004-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004082630-A3
titleOfInvention High potency dopaminergic treatment of neurological impairment associated with brain injury
abstract Methods and compositions are described for treating impaired neurological function, including altered state of consciousness disorders, in an individual who has sustained a brain injury comprising administering to the individual apomorphine. Methods and compositions are described for treating impaired neurological function, including altered state of consciousness disorders, in an individual who has sustained a brain injury comprising administering to the individual at least 1000mg or more of L-dopa (levodopa) per day. The use of potent dopaminergic agents to stimulate emergence form an altered consciousness state, such as a coma, is disclosed.
priorityDate 2003-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6310085-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3961060-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399716
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503384

Total number of triples: 42.